State Street Corp Scopus Bio Pharma Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.6 - $1.7 $497 - $1,409	829 Added 4.17%	20,729 $14,000
Q3 2021 Nov 15, 2021	BUY	$4.0 - $6.99 $79,600 - $139,101	19,900 New	19,900 $83,000
Q2 2021 Aug 16, 2021	SELL	$5.17 - $10.25 $210,698 - $417,728	-40,754 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.94 - $14.87 $323,586 - $606,011	40,754 New	40,754 $344,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.